Cargando…

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD

We characterized a unique group of patients with neuromyelitis optica spectrum disorder (NMOSD) who carried autoantibodies of aquaporin-4 (AQP4) and myelin-oligodendrocyte glycoprotein (MOG). Among the 125 NMOSD patients, 10 (8.0%) were AQP4- and MOG-ab double positive, and 14 (11.2%) were MOG-ab si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yaping, Li, Yujing, Fu, Ying, Yang, Li, Su, Lei, Shi, Kaibin, Li, Minshu, Liu, Qiang, Borazanci, Aimee, Liu, Yaou, He, Yong, Bennett, Jeffrey L., Vollmer, Timothy L., Shi, Fu-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101174/ https://www.ncbi.nlm.nih.gov/pubmed/26920678 http://dx.doi.org/10.1007/s11427-015-4997-y

Ejemplares similares

Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
por: Duan, Yunyun, et al.
Publicado: (2021)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
por: Spadaro, Melania, et al.
Publicado: (2016)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
por: Messina, Silvia, et al.
Publicado: (2021)

Epitope specificity of demyelinating MOG-specific autoantibody responses
por: Brehm, U., et al.
Publicado: (1998)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021)

Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
por: Serguera, Che, et al.
Publicado: (2019)

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
por: Fragoso, Diego Cardoso, et al.
Publicado: (2023)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
por: Gao, Chenyang, et al.
Publicado: (2021)

A Comparative Analysis of Clinical and Imaging Features of Aquaporin 4 (AQP4) Antibody Positive, Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive and Double Seronegative Subtypes of Neuro Myelitis Optica Spectrum Disorder (NMOSD)
por: Gupta, Salil, et al.
Publicado: (2022)

Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study
por: Tian, De-Cai, et al.
Publicado: (2020)

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
por: Kaneko, Kimihiko, et al.
Publicado: (2018)

Corrigendum to ‘Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study’
por: Tian, De-Cai, et al.
Publicado: (2021)

Human C5-specific single-chain variable fragment ameliorates brain injury in a model of NMOSD
por: Zhu, Wenli, et al.
Publicado: (2019)

Correction: CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
Publicado: (2019)

Impaired Meningeal Lymphatic Flow in NMOSD Patients With Acute Attack
por: Wang, Xinxin, et al.
Publicado: (2021)

Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022)

Paraneoplastic encephalomyeloradiculits with multiple autoantibodies against ITPR-1, GFAP and MOG: case report and literature review
por: Cirkel, Anna, et al.
Publicado: (2021)

Clinical characteristics of MOG antibody disease: two case reports
por: Guan, Yujia, et al.
Publicado: (2021)

Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort
por: Dauby, Solène, et al.
Publicado: (2021)

Identification of circulating MOG-specific B cells in patients with MOG antibodies
por: Winklmeier, Stephan, et al.
Publicado: (2019)

ACT001 Relieves NMOSD Symptoms by Reducing Astrocyte Damage with an Autoimmune Antibody
por: Li, Hongen, et al.
Publicado: (2023)

Lupus and NMOSD: The Blending of Humoral Autoimmunity
por: Ochi, Maria Goretti S., et al.
Publicado: (2020)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

Contemporary management challenges in seropositive NMOSD
por: Costello, Fiona, et al.
Publicado: (2022)

Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD)
por: Gernert, Jonathan A., et al.
Publicado: (2022)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Blood pressure and body fat percent in women with NMOSD
por: Chen, Xiaohong, et al.
Publicado: (2019)

The First Case Report of Preschool-Onset SS/SLE Coexisting With NMOSD of Chinese Origin
por: Liu, Liqun, et al.
Publicado: (2022)

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
por: Gourh, Pravitt, et al.
Publicado: (2020)

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review
por: Tanaka, Keiko, et al.
Publicado: (2023)

Plasmapheresis for NMOSD: Not a Rescue Therapy Anymore!?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Plegia to walking: AHSCBMT in severe NMOSD relapse
por: Carlisle, Nicola, et al.
Publicado: (2020)

Therapy challenges for NMOSD in a patient with HIV
por: Engels, Daniel, et al.
Publicado: (2023)

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD
por: Cook, Lawrence J., et al.
Publicado: (2019)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7an3b15r04ggi3r6at45tp7tfe